Advertisement
Canada markets close in 2 hours 19 minutes
  • S&P/TSX

    21,972.97
    +87.59 (+0.40%)
     
  • S&P 500

    5,108.05
    +59.63 (+1.18%)
     
  • DOW

    38,294.76
    +208.96 (+0.55%)
     
  • CAD/USD

    0.7314
    -0.0009 (-0.12%)
     
  • CRUDE OIL

    83.81
    +0.24 (+0.29%)
     
  • Bitcoin CAD

    87,349.55
    -1,029.88 (-1.17%)
     
  • CMC Crypto 200

    1,327.17
    -69.37 (-4.77%)
     
  • GOLD FUTURES

    2,346.90
    +4.40 (+0.19%)
     
  • RUSSELL 2000

    2,004.67
    +23.55 (+1.19%)
     
  • 10-Yr Bond

    4.6770
    -0.0290 (-0.62%)
     
  • NASDAQ

    15,949.14
    +337.38 (+2.16%)
     
  • VOLATILITY

    15.05
    -0.32 (-2.08%)
     
  • FTSE

    8,139.83
    +60.97 (+0.75%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6837
    +0.0016 (+0.23%)
     

Why ChemoCentryx Stock Is On Fire Today

Why ChemoCentryx Stock Is On Fire Today

Shares of ChemoCentryx (NASDAQ: CCXI) skyrocketed by as much as 110% in premarket trading Thursday morning. The company's stock bolted higher following the news that biotech heavyweight Amgen (NASDAQ: AMGN) offered $3.7 billion in cash to acquire the rare-disease specialist. The deal represents a whopping 116% premium relative to where ChemoCentryx's shares closed on Wednesday.